ICVTS Click here to go to Siemens website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published on May 8, 2008
Interactive CardioVascular and Thoracic Surgery 2008, doi:10.1510/icvts.2007.167924
© 2008 European Association of Cardio-Thoracic Surgery

This Article
Right arrow Full Text (Journal Format PDF)
Right arrow eComments: Submit
Right arrow Alert me when this article is cited
Right arrow Alert me when eComments are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Manuel Antunes
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Antunes, M.
Right arrow Articles by Providencia, L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antunes, M.
Right arrow Articles by Providencia, L.
Related Collections
Right arrow Transplantation - heart

Transplantation

Cardiac allograft systolic function. Is the aetiology (ischaemic or idiopathic) a determinant of ventricular function in the heart transplant patient?

Manuel Antunes 1*, Martha Biernat 1, Emilia Sola 1, Luis Oliveira 1, David Prieto 1, Fatima Franco 1, Luis Providencia 1

1 Coimbra University Hospital, Portugal

* To whom correspondence should be addressed. E-mail: antunes.cct.huc{at}sapo.pt.


   Abstract
The natural history of the LV systolic function (LV-SF) and functional capacity of survivors of heart transplantation (Htx) has not been defined. Some investigators suggest that SF may be different in recipients with different pre-transplant etiologies: ischaemic or dilated, idiopathic disease. Routine transthoracic echocardiograms (TTE) were performed during a 1-year follow-up in 48 Htx recipients (total 864 examinations; mean 18/patient). Patients were divided into two groups based on pre-transplant diagnosis: ischaemic (CAD-CMP: n=13, age 54±1.7 years, 23% females) and idiopathic dilated cardiomyopathy (ID-CMP: n=35, age 51±2.3 years, 26% females). Patients with valvular and toxic aetiology were excluded. All patients underwent left ventriculography (VENT) 12-15 months after Htx. The majority of 1-year survivors of Htx maintained normal LV-SF: mean LVEF 65±4% by echocardiography and 68±3% by ventriculography, but in the ID-CMP group LVEF was significantly higher: 67±4% vs. 62±4% (TTE) and 77±4% vs. 60±4% (VENT), without significant differences in functional capacity (NYHA). 82.9% of ID-CMP patients had LVEF >65% vs. 39% in CAD-CMP. The incidence of acute cellular rejection, freedom from cardiac vasculopathy, renal failure, diabetes, hypertension and pre-transplant alloantibody level was similar. Our study shows a strong correlation between pre-transplant heart disease and the systolic function of the cardiac allograft at 1-year follow-up. Keywords: Heart transplantation; LV function; Echocardiography





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 European Association for Cardio-thoracic Surgery